5 Best Genomics Stocks To Buy Now

Page 1 of 5

In this article, we discuss the 5 best genomics stocks to buy now. If you want to read about some more genomics stocks, go directly to 13 Best Genomics Stocks To Buy Now.

5. Agilent Technologies, Inc. (NYSE:A)

Number of Hedge Fund Holders: 46    

Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. On November 21, Agilent Technologies posted earnings for the fourth quarter of 2022, reporting earnings per share of $1.53, beating market estimates by $0.14. The revenue over the period was $1.85 billion, up 11.4% compared to the revenue over the same period last year and beating market estimates by $90 million. 

On November 22, Jefferies analyst Brandon Couillard maintained a Buy rating on Agilent Technologies, Inc. (NYSE:A) stock and raised the price target to $168 from $158, highlighting that company’s initial FY23 guidance that assumes normalized core growth of 5%-6.5% seems to be a prudent starting point given the macro backdrop and tough comps.  

Among the hedge funds being tracked by Insider Monkey, London-based investment firm Impax Asset Management is a leading shareholder in Agilent Technologies, Inc. (NYSE:A) with 4 million shares worth more than $487.9 million. 

Page 1 of 5